Headache

N1-Headache: a tool for personalized migraine management 2:00
N1-Headache: a tool for personalized migraine management
Christian Wöber • 14 Jun 2021
How does eptinezumab differ from other migraine treatments? 2:27
How does eptinezumab differ from other migraine treatments?
Roger Cady • 15 Jun 2021
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack 4:47
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack
Roger Cady • 15 Jun 2021
Visuospatial processing in patients with migraine 3:21
Visuospatial processing in patients with migraine
Roberta Messina • 17 Jun 2021
Imaging biomarkers in migraine 2:52
Imaging biomarkers in migraine
Roberta Messina • 17 Jun 2021
Beyond CGRP: psychedelics for the treatment of migraine 4:16
Beyond CGRP: psychedelics for the treatment of migraine
Jessica Ailani • 21 Jun 2021
Lessons learned from neuroimaging in migraine 2:21
Lessons learned from neuroimaging in migraine
Roberta Messina • 17 Jun 2021
Migraine symptom resolution occurs within an hour with eptinezumab administered during an attack 6:17
Migraine symptom resolution occurs within an hour with eptinezumab administered during an attack
Jessica Ailani • 21 Jun 2021
Total pain burden reduced by galcanezumab in treatment-resistant migraine 6:19
Total pain burden reduced by galcanezumab in treatment-resistant migraine
Jessica Ailani • 21 Jun 2021
Resting state functional connectivity changes of the pons in migraine 2:52
Resting state functional connectivity changes of the pons in migraine
Roberta Messina • 17 Jun 2021
Can patients predict an upcoming cluster headache bout? 1:45
Can patients predict an upcoming cluster headache bout?
Rigmor Jensen • 11 Jun 2021
Cluster headache: unmet needs in a disabling condition 1:34
Cluster headache: unmet needs in a disabling condition
Rigmor Jensen • 11 Jun 2021
Impact of sex and gender on migraine management 2:06
Impact of sex and gender on migraine management
Elena Lebedeva • 7 Jun 2021
Impact of sex and gender on migraine clinical presentation 1:44
Impact of sex and gender on migraine clinical presentation
Elena Lebedeva • 7 Jun 2021
Real-world effectiveness of fremanezumab for migraine prevention 1:23
Real-world effectiveness of fremanezumab for migraine prevention
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
The future of migraine prevention with CGRP-targeted agents 2:14
The future of migraine prevention with CGRP-targeted agents
Dimos-Dimitrios Mitsikostas • 15 Jun 2021
The content of VJNeurology is intended for healthcare professionals